161 related articles for article (PubMed ID: 21938204)
1. Ligand based virtual screening to find novel inhibitors against plant toxin Ricin by using the ZINC database.
Mishra V; Siva Prasad CV
Bioinformation; 2011; 7(2):46-51. PubMed ID: 21938204
[TBL] [Abstract][Full Text] [Related]
2. Discovery of RTA ricin subunit inhibitors: a computational study using PM7 quantum chemical method and steered molecular dynamics.
Chaves EJF; Gomes da Cruz LE; Padilha IQM; Silveira CH; Araujo DAM; Rocha GB
J Biomol Struct Dyn; 2022 Aug; 40(12):5427-5445. PubMed ID: 33526002
[TBL] [Abstract][Full Text] [Related]
3. Identification of new classes of ricin toxin inhibitors by virtual screening.
Bai Y; Watt B; Wahome PG; Mantis NJ; Robertus JD
Toxicon; 2010 Sep; 56(4):526-34. PubMed ID: 20493201
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of ricin inhibitors.
Jasheway K; Pruet J; Anslyn EV; Robertus JD
Toxins (Basel); 2011 Oct; 3(10):1233-48. PubMed ID: 22069693
[TBL] [Abstract][Full Text] [Related]
5. A Supercluster of Neutralizing Epitopes at the Interface of Ricin's Enzymatic (RTA) and Binding (RTB) Subunits.
Poon AY; Vance DJ; Rong Y; Ehrbar D; Mantis NJ
Toxins (Basel); 2017 Nov; 9(12):. PubMed ID: 29168727
[TBL] [Abstract][Full Text] [Related]
6. Identification and Biological Evaluation of a Novel Small-Molecule Inhibitor of Ricin Toxin.
Yang X; Wei A; Cao X; Wang Z; Wan H; Wang B; Peng H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611715
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Inhibitors Targeting the Interaction of Ricin Toxin A Subunit with Ribosomes.
Li XP; Harijan RK; Kahn JN; Schramm VL; Tumer NE
ACS Infect Dis; 2020 Jul; 6(7):1894-1905. PubMed ID: 32428396
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection of RNA molecules that inhibit the activity of ricin A-chain.
Hesselberth JR; Miller D; Robertus J; Ellington AD
J Biol Chem; 2000 Feb; 275(7):4937-42. PubMed ID: 10671531
[TBL] [Abstract][Full Text] [Related]
9. Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors.
Botelho FD; Dos Santos MC; Gonçalves ADS; Kuca K; Valis M; LaPlante SR; França TCC; de Almeida JSFD
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33256167
[TBL] [Abstract][Full Text] [Related]
10. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
12. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of ricin toxin A chain complexed with a highly potent pterin-based small-molecular inhibitor.
Goto M; Sakamoto N; Higashi S; Kawata R; Nagatsu K; Saito R
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2219038. PubMed ID: 37259593
[TBL] [Abstract][Full Text] [Related]
14. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
[TBL] [Abstract][Full Text] [Related]
15. Determining the Relative Binding Affinity of Ricin Toxin A Inhibitors by Using Molecular Docking and Nonequilibrium Work.
Chaves EJF; Padilha IQM; Araújo DAM; Rocha GB
J Chem Inf Model; 2018 Jun; 58(6):1205-1213. PubMed ID: 29750861
[TBL] [Abstract][Full Text] [Related]
16. Co-application of ricin A chain and a recombinant adenovirus expressing ricin B chain as a novel approach for cancer therapy.
Wang HB; Xia F; Ge J; Yin J; Tan LS; Zhang PD; Zhong J
Acta Pharmacol Sin; 2007 May; 28(5):657-62. PubMed ID: 17439722
[TBL] [Abstract][Full Text] [Related]
17. High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin.
Vance DJ; Tremblay JM; Rong Y; Angalakurthi SK; Volkin DB; Middaugh CR; Weis DD; Shoemaker CB; Mantis NJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021300
[TBL] [Abstract][Full Text] [Related]
18. Structure-based identification of a ricin inhibitor.
Yan X; Hollis T; Svinth M; Day P; Monzingo AF; Milne GW; Robertus JD
J Mol Biol; 1997 Mar; 266(5):1043-9. PubMed ID: 9086280
[TBL] [Abstract][Full Text] [Related]
19. Conformational change in ricin toxin A-Chain: A critical factor for inhibitor binding to the secondary pocket.
Goto M; Higashi S; Ohba T; Kawata R; Nagatsu K; Suzuki S; Anslyn EV; Saito R
Biochem Biophys Res Commun; 2022 Oct; 627():1-4. PubMed ID: 35998389
[TBL] [Abstract][Full Text] [Related]
20. Differential neutralizing activities of a single domain camelid antibody (VHH) specific for ricin toxin's binding subunit (RTB).
Herrera C; Vance DJ; Eisele LE; Shoemaker CB; Mantis NJ
PLoS One; 2014; 9(6):e99788. PubMed ID: 24918772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
